Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

26.52
+1.797.24%
Post-market: 26.19-0.3300-1.24%19:38 EST
Volume:1.35M
Turnover:35.32M
Market Cap:2.69B
PE:-6.00
High:26.68
Open:25.63
Low:25.21
Close:24.73
52wk High:36.44
52wk Low:13.53
Shares:101.47M
Float Shares:89.94M
Volume Ratio:0.89
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4193
EPS(LYR):-4.5769
ROE:-47.19%
ROA:-23.48%
PB:2.79
PE(LYR):-5.79

Loading ...

Beam Therapeutics announces upcoming board member resignation

TIPRANKS
·
Yesterday

Beam Therapeutics Director Carole Ho Resigns

Reuters
·
Yesterday

Beam Therapeutics Chief Legal Officer Christine Bellon Reports Sale of Common Shares

Reuters
·
Jan 27

JonesTrading Sticks to Its Buy Rating for Beam Therapeutics (BEAM)

TIPRANKS
·
Jan 23

Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path

TIPRANKS
·
Jan 23

Beam Therapeutics SVP Finance Bethany J. Cavanagh Reports Disposal of Common Shares

Reuters
·
Jan 22

Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating

TIPRANKS
·
Jan 21

U.S. RESEARCH ROUNDUP-IBM, KLA, WEX

Reuters
·
Jan 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX), Beam Therapeutics (BEAM) and Boston Scientific (BSX)

TIPRANKS
·
Jan 21

Beam Therapeutics Chief Legal Officer Christine Bellon Reports Disposal of Common Shares

Reuters
·
Jan 21

Bernstein Keeps Their Buy Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
Jan 14

Gene Therapy Development Progress Sends Beam Therapeutics (BEAM.US) Shares Soaring

Stock News
·
Jan 13

Beam Therapeutics Stock Surges: What's Driving The Sudden Jump?

Benzinga_recent_news
·
Jan 13

Beam Therapeutics Up Over 27%, on Track for Record Percent Increase -- Data Talk

Dow Jones
·
Jan 13

Beam Therapeutics Shares Climb After Updates to Treatment-Candidate Pipelines

Dow Jones
·
Jan 13

Beam FDA alignment could accelerate review, says William Blair

TIPRANKS
·
Jan 13

Beam Therapeutics higher after reaching FDA alignment on BEAM-302

TIPRANKS
·
Jan 13

Beam Therapeutics rises 23.4%

TIPRANKS
·
Jan 12

BRIEF-Beam Therapeutics Says It Sets Strategic Priorities For Its Genetic Disease & Hematology Franchises

Reuters
·
Jan 12

Beam Therapeutics Extends Cash Runway Into 2029 and Advances Clinical Programs

Reuters
·
Jan 12